Compound ID | 155
Class: Antibiofilm agent
| Agent Type: | Synthetic; Small molecule; Antibiofilm; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Clostridium difficile infections (CDI) and oral anaerobic pathogens |
| Propensity to select resistant mutants: | Yes |
| Description: | A nitazoxanide derivative |
| Institute where first reported: | Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA |
| Year first mentioned: | 2012 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |